222 related articles for article (PubMed ID: 19902545)
1. Angiopoietin-2 in experimental colitis.
Ganta VC; Cromer W; Mills GL; Traylor J; Jennings M; Daley S; Clark B; Mathis JM; Bernas M; Boktor M; Jordan P; Witte M; Alexander JS
Inflamm Bowel Dis; 2010 Jun; 16(6):1029-39. PubMed ID: 19902545
[TBL] [Abstract][Full Text] [Related]
2. COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.
Lee AS; Sung MJ; Kim W; Jung YJ
J Mol Med (Berl); 2018 May; 96(5):459-467. PubMed ID: 29610929
[TBL] [Abstract][Full Text] [Related]
3. Investigating intestinal inflammation in DSS-induced model of IBD.
Kim JJ; Shajib MS; Manocha MM; Khan WI
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
[TBL] [Abstract][Full Text] [Related]
4. Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model.
Daley SK; Witte MH; Washington J; Bernas M; Kiela P; Thorn J; Tanoue N; Alexander JS
Inflamm Bowel Dis; 2019 Nov; 25(12):1919-1926. PubMed ID: 31173626
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.
Ito R; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Kita M; Ueda Y; Iwakura Y; Kataoka K; Okanoue T; Mazda O
Clin Exp Immunol; 2006 Nov; 146(2):330-8. PubMed ID: 17034586
[TBL] [Abstract][Full Text] [Related]
6. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
7. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
8. Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.
Wang XL; Zhao J; Qin L; Qiao M
Braz J Med Biol Res; 2016; 49(5):e4738. PubMed ID: 27074165
[TBL] [Abstract][Full Text] [Related]
9. Type I interferons have opposing effects during the emergence and recovery phases of colitis.
Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T
Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266
[TBL] [Abstract][Full Text] [Related]
10. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
Xu Y; Hunt NH; Bao S
Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
[TBL] [Abstract][Full Text] [Related]
11. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.
Darsigny M; St-Jean S; Boudreau F
Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487
[TBL] [Abstract][Full Text] [Related]
12. IF1 inactivation attenuates experimental colitis through downregulation of neutrophil infiltration in colon mucosa.
Zhong G; Zhang J; Guo Y; Wang Y; Wu M; Ren J; Li Y; Zhang X; Zhou B; Zhao W; Lou Y; Wang H; Ye J
Int Immunopharmacol; 2021 Oct; 99():107980. PubMed ID: 34298397
[TBL] [Abstract][Full Text] [Related]
13. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis.
Yan Y; Kolachala V; Dalmasso G; Nguyen H; Laroui H; Sitaraman SV; Merlin D
PLoS One; 2009 Jun; 4(6):e6073. PubMed ID: 19562033
[TBL] [Abstract][Full Text] [Related]
14. Mouse strain influences angiogenic response to dextran sodium sulfate-induced colitis.
Knod JL; Crawford K; Dusing M; Frischer JS
J Surg Res; 2014 Jul; 190(1):47-54. PubMed ID: 24793451
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
16. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
17. Gp91(phox) contributes to the development of experimental inflammatory bowel disease.
Bao S; Carr ED; Xu YH; Hunt NH
Immunol Cell Biol; 2011 Nov; 89(8):853-60. PubMed ID: 21321580
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis.
Hosono K; Kojo K; Narumiya S; Majima M; Ito Y
Biomed Pharmacother; 2020 Aug; 128():110264. PubMed ID: 32447215
[TBL] [Abstract][Full Text] [Related]
19. MD-1 deficiency attenuates dextran sodium sulfate (DSS)-induced colitis through modulating the function of colonic lamina propria dendritic cells.
Pan H; Zhang G; Zhang L; Wang W; Shang J; Wang X; Zhao Q; Li J
Mol Immunol; 2016 Jul; 75():1-10. PubMed ID: 27209086
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
